Biodel to Report First Quarter Fiscal Year 2013 Financial Results on February
DANBURY, Conn., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD)
will issue its first quarter fiscal year 2013 financial results on February
12, 2013. Following the release of the company's financial results, Biodel's
senior management will host a conference call to discuss the results and
provide an update on the company's progress.
February 12, 2013 schedule:
4:30 pm ET: First Quarter fiscal year 2013 results will be distributed
4:45 pm ET: Conference call participants should dial:
+1 ( 877 ) 303 - 8028 (United States) or
+1 ( 760 ) 536 - 5167 (International)
5:00 pm ET: Conference call begins
Interested parties may access a live audio webcast of the conference call in
the investor section of Biodel's website at www.biodel.com. The audio webcast
will be archived and available for replay through the website.
About Biodel Inc.
Biodel Inc.is a specialty biopharmaceutical company focused on the
development and commercialization of innovative treatments for diabetes that
may be safer, more effective and more convenient for patients. We develop our
product candidates by applying our proprietary formulation technologies to
existing drugs in order to improve their therapeutic profiles.
CONTACT: Seth D. Lewis, +1-646-378-2952
Press spacebar to pause and continue. Press esc to stop.